Fennec Pharmaceuticals is trading 6.58% up now at $11.66 as investors positioned ahead of its second-quarter 2026 financial results, due before the U.S. market opens on August 11, 2026.
- The company scheduled an 8:30 a.m. Eastern conference call to discuss results and business updates.
- The pre-market gain follows a 5.49% regular-session decline on August 10.